MY129121A - Composition with azelaic acid - Google Patents

Composition with azelaic acid

Info

Publication number
MY129121A
MY129121A MYPI9805271A MY129121A MY 129121 A MY129121 A MY 129121A MY PI9805271 A MYPI9805271 A MY PI9805271A MY 129121 A MY129121 A MY 129121A
Authority
MY
Malaysia
Prior art keywords
composition
azelaic acid
triacylglycerides
melasma
polysorbates
Prior art date
Application number
Inventor
Clemens Dr Gunther
Jutta Dr Riedl
Patrick Dr Franke
Original Assignee
Intendis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intendis Gmbh filed Critical Intendis Gmbh
Publication of MY129121A publication Critical patent/MY129121A/en

Links

Abstract

THE INVENTION RELATES TO A PHARMACEUTICAL COMPOSITION WHICH HAS THE FOLLOWING INGREDIENTS: AZELAIC ACID, POLYACRYLIC ACID, TRIACYLGLYCERIDES, PROPYLENE GLYCOL, POLYSORBATES, SOYA LECITHIN, WATER AND SALTS. THE COMPOSITION IS A HYDROGEL SUITABLE FOR TREATING ROSACEA, AGE SPOTS, MELASMA OR DERMAL IRRITATION.
MYPI9805271 1997-11-19 1998-11-19 Composition with azelaic acid MY129121A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19753044 1997-11-19
DE19808086 1998-02-20

Publications (1)

Publication Number Publication Date
MY129121A true MY129121A (en) 2007-03-30

Family

ID=45605764

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9805271 MY129121A (en) 1997-11-19 1998-11-19 Composition with azelaic acid

Country Status (3)

Country Link
AR (1) AR013769A1 (en)
MY (1) MY129121A (en)
PE (1) PE20000026A1 (en)

Also Published As

Publication number Publication date
AR013769A1 (en) 2001-01-10
PE20000026A1 (en) 2000-02-11

Similar Documents

Publication Publication Date Title
ZA971583B (en) Treatment of contact lenses with aqueous solution including phosphonic compounds.
HK1030753A1 (en) Fracture healing using pthrp analogs.
CA2311128A1 (en) Composition with azelaic acid
TNSN97009A1 (en) 2-OXO- AND 2-THIO- 1,2- DIHYDROQUINOLEINYL-OXAZOLIDINONES.
ID22878A (en) ACTIVE COMPOSITION THERAPY
BR8902066A (en) COMPOSITION FOR TISSUE TREATMENT, LIQUID, NON WATER
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
WO2001041747A3 (en) Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating cancer
FR2749514B1 (en) TRANSDERMAL SYSTEMS CONTAINING 2 ACTIVE INGREDIENTS IN SEPARATE COMPARTMENTS, THEIR PREPARATION METHOD AND THEIR APPLICATION AS A MEDICAMENT
ZA978226B (en) Fatty acid treatment.
MY129121A (en) Composition with azelaic acid
EP0268135A3 (en) Coccidiocidal agents
PT983300E (en) BPC PEPTIDIC SALTS WITH ORGAN-PROTECTIVE ACTIVITY, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPY
IT1290910B1 (en) 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, ACTIVE
DE69000791D1 (en) THERAPEUTIC AGENTS FOR METABOLIC BONE DISEASES.
CA2248753A1 (en) Use of olanzapine for treating excessive aggression
DE3770881D1 (en) LIQUIDATING AGENT FOR TEXTILE TREATMENT.
IT8720800A0 (en) ACTIVE COMPOUND IN CARCIOVASCULAR THERAPY.
ITBO930155A0 (en) HETEROCICLIC COMPOUNDS ACTIVE IN GASTRO-INTESTINAL DISEASES.
RU2000106182A (en) Means for treating skin lesions of various etiology
FR2653023B1 (en) IMPROVED ELECTRODE SYSTEM FOR USE IN ELECTROTHERAPY OR IONOPHORESIS.
RS49796B (en) USE OF 3α, 7α-DIHIDROXY-12-KETO-5βB-CHOLANIC ACID SALTS IN THE PREPARATION OF MEDICAMENT FOR THE TREATMENT OF DIABETES
HUP9801869A2 (en) Pharmaceutical composition for enhancing level of l-carnitin in human patients
RU97111440A (en) DRUG FOR TREATING FROZEN